Harbor Capital Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Harbor Capital Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$14.28 - $31.03 $33,258 - $72,268	2,329 Added 7.06%	35,303 $1.04 Million
Q3 2023 Oct 20, 2023	BUY	$19.33 - $36.22 $1,024 - $1,919	53 Added 0.16%	32,974 $684,000
Q2 2023 Jul 11, 2023	BUY	$24.18 - $42.46 $796,029 - $1.4 Million	32,921 New	32,921 $807,000
Q2 2022 Jul 26, 2022	SELL	$53.22 - $123.09 $570,997 - $1.32 Million	-10,729 Closed	0 $0
Q1 2022 Apr 28, 2022	SELL	$101.89 - $150.09 $159,457 - $234,890	-1,565 Reduced 12.73%	10,729 $1.25 Million
Q4 2021 Feb 04, 2022	BUY	$118.18 - $153.21 $1.45 Million - $1.88 Million	12,294 New	12,294 $1.85 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.94B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.